Avian sarcoma virus PR2257 transduced de novo the csrc gene and about 900 bp of 3' non-coding sequences belonging to the src locus. This virus contains only one mutation in the c-src coding sequence causing a reading frame shift after Pro-525. The molecular clone studied was derived from a cell line of transformed quail fibroblasts, C7. It contains endogenous virus (ev) derived sequences in the U5 and 3' non-coding regions, indicating that multiple recombination occurred with endogenous virus. Here we investigated the possible evolution of PR2257 when the original tumour was repeatedly passaged in vivo. After 16 passages a new virus, designated PR2257/16, appeared with a tenfold higher titre. The sequence ofPR2257/16 was determined and showed that PR2257/16 resulted from recombination of PR2257 with the env gene of the helper virus (td daPR-C). This recombination expanded the env gene content in PR2257/16 and, in addition, five point mutations occurred in its genome. Because we thought that an endogenous virus might be involved in the mechanism of c-src transduction, we also reinvestigated the presence of ev sequences in PR2257 proviruses from several early passages of the original tumour. We found that in contrast with the first isolate from the C7 cell line, the provirus in these tumours did not contain such sequences. These results do not support the hypothesis that endogenous sequences were involved in the transduction process.
Avian sarcoma virus PR2257 transduced de novo the csrc gene and about 900 bp of 3' non-coding sequences belonging to the src locus. This virus contains only one mutation in the c-src coding sequence causing a reading frame shift after Pro-525. The molecular clone studied was derived from a cell line of transformed quail fibroblasts, C7. It contains endogenous virus (ev) derived sequences in the U5 and 3' non-coding regions, indicating that multiple recombination occurred with endogenous virus. Here we investigated the possible evolution of PR2257 when the original tumour was repeatedly passaged in vivo. After 16 passages a new virus, designated PR2257/16, appeared with a tenfold higher titre. The sequence ofPR2257/16 was determined and showed that PR2257/16 resulted from recombination of PR2257 with the env gene of the helper virus (td daPR-C). This recombination expanded the env gene content in PR2257/16 and, in addition, five point mutations occurred in its genome. Because we thought that an endogenous virus might be involved in the mechanism of c-src transduction, we also reinvestigated the presence of ev sequences in PR2257 proviruses from several early passages of the original tumour. We found that in contrast with the first isolate from the C7 cell line, the provirus in these tumours did not contain such sequences. These results do not support the hypothesis that endogenous sequences were involved in the transduction process.
The replication competent strains of Rous sarcoma virus (RSV) are exceptional in that they contain a complete set of replicative genes in addition to the transduced oncogene sequences. In this respect, they differ markedly from all other acutely transforming retroviruses, in which a large part of the replicative genes have been lost during transduction of cellular proto-oncogenes. However, since both the Bryan strain of RSV (Lerner & Hanafusa, 1984) and RSV29 (Dutta et al., 1985) , the closest isolate to the original Rous tumour virus, lack the env gene, it is likely that the ancestral virus was also replication defective. Clues for the generation of RSV might be obtained by study of the possible evolution towards forms closer to RSV29 of new src transducing viruses during repeated passaging. We have described such a new src transducing virus, the avian sarcoma virus PR2257 (Geryk et al., 1989) ; this virus was obtained from a sarcoma induced by intraembryonal inoculation of td daPR-C, a transformation-defective mutant of the Prague-C strain of RSV adapted to growth in duck fibroblasts, (Svoboda et al., 1984) . The td daPR-C employed was devoid of src sequence (Kashuba et al., 1989) . In PR2257, c-src was modified to an oncogene by a frameshift mutation in the last coding exon. In addition, PR2257 had acquired 900 bp of non-coding sequences belonging to the 3' region of the c-src locus. All replicative genes were absent, except for the 3' region of env (Geryk et al., 1989 ). An interesting characteristic of PR2257 structure is the linkage by a splice junction of the viral leader sequences to the first c-src exon present in RSV. This feature suggests that one of the early steps of src capture is the formation of a transcript in which the viral leader is spliced to this exon of c-src. This is consistent with our description of early steps in the transduction of mil/rafgenes in neuroretina cells in vitro infected with Rous associated virus type 1 (Marx et al., 1988; Eych~ne et al., 1990; Felder et al., 1991 Felder et al., , 1993 .
We also investigated the possible role of endogenous virus (ev) sequences that were found in the virus from the quail cell line C7 used to clone PR2257 (Geryk et al., 1989) . Such sequences were present in U5, at the end of env, and the downstream non-coding region. We thought that their presence might indicate that the c-src gene was transduced by a recombinant of td daPRC with ev which would be, for unknown reasons, more efficient than the original td daPRC in src gene transducfion. This 0001-2546© 1994 SGM figure) . The genotype of U5 and env 3' regions is indicated by ev or td, when they contained respectively ev derived sequences or t d daPR-C sequences. hypothesis was supported by several reports: it was shown that NTRE7, a transformation-defective recombinant of PR-B RSV with RAV-0 which has the same ev sequences in env and the 3' non-coding region as PR2257, is more efficient in the induction of sarcomas than viruses devoid of ev sequences, such as Rous associated virus type 1 (RAV-1) and 2, which essentially induce lymphomas and erythroblastosis (Robinson et al., 1982; Tsichlis et al., 1982) . Also, it was shown that in three independent transductions of the ras gene which led to three strains of Murine sarcoma virus, the transducing virus was a recombinant of Murine leukaemia virus with the murine endogenous retrotransposon VL30 (Makris et al., 1993) . Recently, the description of the structure of ART-CH, a new type of avian endogenous retroviral element which is similar to the murine VL30, showed that sequences derived from ART-CH are present in the 3' non-coding region of four acutely transforming avian retroviruses which had transduced four different oncogenes, src in RSV, m y c in MH2, f p s in PRCII and crk in CT10 (Gudkov et al., 1992; Nikiforov & Gudkov, 1994) . Because recombinations with ev sequences might have taken place during the isolation of the C7 line, it was of interest to determine whether the same ev related sequences are also present in other isolates of PR2257. Since neither the DNA of the original tumour nor that of its first passage in chicken were available, we analysed that of the earliest available passages in chicken and in quail (Fig. 1) .
The possible evolution of PR2257 was followed by studying functional and structural changes of the virus during serial in vivo passaging of the original PR2257induced chicken sarcoma. We employed this strategy because of the severe defectiveness of this ,Arus, which restricts its replicative capacity in vitro. At the 16th passage, we observed a tenfold increase in the transforming titre. This increase was significant because the transforming titre of the original PR2257 was only 10 focus forming units/ml (Svoboda et al., 1984) , and suggested the appearance of a new virus. This was confirmed by analysis of tumour DNA with a src probe (the N c o I -S a c I 1.6 kbp fragment of PR2257), which revealed the presence of a new E c o R I fragment of 3.5 kbp instead of the 4"1 kbp fragment corresponding to the entire PR2257 provirus (data not shown). The virus which evolved from PR2257 after 16 passages was designated PR2257/16. The 3"5 kbp E c o R I fragment was cloned in 2 G T l l and sequenced. Sequencing data showed that this fragment is bounded by E c o R I sites in the 5' long terminal repeat (LTR) and the env gene and, therefore, lacks the 3' region of the complete provirus. It also showed that PR2257/16 was derived from PR2257 by recombination, within the src 3' non-coding sequences, with the env gene of t d daPR-C (Fig. 2 a) . This recombination expanded the part of env already present in PR2257. Recombination was facilitated by a region of 13 nucleotides in which the env gene differs only by one gap from the sequence of the PR2257 3' src region (Fig.  2b ). Such homologies are frequently observed in recombinations between retroviruses and are believed to be sites for reverse transcriptase strand switching. To complete the sequence of PR2257/16, the Y region was isolated from tumour DNA by PCR amplification, using oligonucleotides (see Fig. 2a ) in the src 3' non-coding sequences (
G T C C A C C G G A G T G T T T C T A G positions 2897 to 2916 in the PR2257 sequence) and in the L T R ( C A A T A T C T C T G C G A T G C G G complementary to
positions 4264 to 4282 in PR2257). The amplified fragment of 2-2 kbp was subcloned and sequenced. This region was found to be identical to that of t d daPR-C virus (Kashuba et al., 1989; Zubak et al., 1990) .
In the region homologous to PR2257, we observed five single nucleotide mutations (Fig. 2a ). In the L T R one mutation at position 248 restores the C in PR2257 to the T which is found in PR-C at this position. A second mutation occurred at position 353, next to the primer binding site (PBS), and restored the normal sequence of avian leukemia and sarcoma viruses at this position, i.e. AT_A_G instead of AT_GG in PR2257. We previously suggested that this mutation might be responsible for the severe replication defectiveness of PR2257, because it created a new strong ribosome binding site in the vicinity of the reverse transcriptase and primer tRNA attachment site (Geryk et al., 1989) . Three other mutations are located in the src coding region. The first one, a C ~ T at position 913, does not change the encoded amino acid, whereas the two others modify the protein sequence: the mutation T ~ C at position 1164 changes Ile-153 to Thr and the mutation C ~ T at position 1616 changes Pro-304 to Ser. The first mutation resides in the SH2 domain and the second is in the catalytic domain at a position which is not highly conserved in cytoplasmic tyrosine kinases (Hanks et al., 1988) . To determine the transforming properties of the src genes of PR2257 and PR2257/16 their coding regions were expressed in chicken cells with a non-replicative retroviral vector. We (a) Comparisons in the LTR region show that PR2257[C7] and PR2257/16 have the same U5 sequence as ev, while PR2257[JQ1] is identical to the original cloned td daPR-C, therefore also to PR-C (sequence not shown). The 3' oligonucleotides used for PCR analysis of tumours BL2 and JQ2 are underlined. PBS, primer binding site. (b) Comparisons at the end of env and the following 3' non-coding region: up to nucleotide 3894, PR2257[C7] is almost identical to ev, in contrast to PR2257[JQ1] and PR2257/16 which are identical to td daPR-C. In these viruses the deletion of src joined the 5' F1D element to the 3' F1A element (with the removal of the first nine bases of this element). The nomenclature of elements of the 3' non-coding region is according to Lerner & Hanafusa (1984). will describe these results in detail elsewhere. Briefly, we observed that both genes had kinase activities similar to that of wild-type v-src, but cells transformed by PR2257/16 were polymorphocellular and round, whereas those transformed by PR2257 exhibited a more fusiform morphology. Moreover, PR2257/16-transformed fibroblasts gave rise to larger colonies in soft agar, similar to those of wild-type v-src-transformed cells. These observations indicate that the src gene of PR2257/16 has intrinsically a higher transforming potential than that of PR2257. In summary, we have shown that serial passaging of PR2257 led to a new virus, PR2257/16, with increased replicative and transforming capacities. These modifications were presumably sufficient to favour selection of PR2257/16 over PR2257. The consequence of the acquisition of env sequences is unclear. In PR2257/16, there is 1521 bp of env sequences instead of 1785 bp for the complete gene. Due to the absence of the 5' region and of the splice acceptor ofenv, these sequences are probably not functional in PR2257/16. In contrast to what was observed by serial passaging of the early forms of mil/Rmil transducing viruses, there was no acquisition of gag sequences upstream of the transduced oncogene (Felder et al., 1991) .
To address the question of the possible role of ev sequences in PR2257, we analysed other early passages of the tumour in chickens and quails (Fig. 1) : the second passage in chicken (tumour BL2) and two passages in quail of the chicken first passage (tumours JQ1 and JQ2), Provirus from turnout JQ1, PR2257[JQI], was isolated from a genomic library obtained by partial digestion of tumour DNA with Sau3A and ligation to EMBL3 arms. Screening with a src probe (see above) allowed the isolation of a clone which contained 3.5 kbp of the 5' region of PR2257[JQ1]. An overlapping 1.1 kbp fragment of the 3' region was amplified from tumour DNA by PCR, using oligonucleotides (see Fig. 2a ) in the 3" noncoding region of src (CCATCACTCACACCCGGTGC, positions 3217 to 3236 of PR2257) and in U3 (same as above). Both fragments were sequenced to obtain the complete sequence of PR2257[JQ1]. Comparison of this sequence with that of PR2257 from C7 cells showed that PR2257[JQ1] does not contain sequences that match ev in U5 (Fig. 3a) nor the 3' end ofenv or the adjacent noncoding region (Fig. 3 b) . These regions were identical to those of td daPR-C.
In tumours JQ2 and BL2, the EcoRI fragments of PR2257 provirus were of apparently identical size to those of PR2257[JQ1] (data not shown). The presence of ev derived sequences in the env 3' region and in the LTR were analysed by PCR. With both tumour DNAs, this region was amplified using a 5' oligonucleotide in the src Y non-coding region (as above) and a 3' oligonucleotide in U5, either with five mutations as in PR2257 from the C7 line, or without such changes as in td daPR-C (see Fig. 3 legend) . In the first case no amplification was observed, whereas in the second we obtained a fragment of 1.6 kbp with both chicken and quail tumour DNA. This suggested that in these two ttunours, U5 was identical to that of PR2257[JQ1]. Both the size of this fragment, 1.6 kbp instead of 1.5 kbp for PR2257 from C7 cells, and the fact that it could be cut with XbaI (a site for which is present in PR2257[JQ1] and absent in PR2257 from the C7 line) showed that ev sequences in env and the adjacent non-coding region were also absent in BL2 and JQ2.
Finally, our results showed that ev sequences were present in PR2257 from the C7 cell line but not in the three early passages of tumour 2257 which were examined. It is likely that they were acquired either by recombination of the original sarcoma virus with ev loci, which are known to be present and expressed in Brown Leghorn chickens (Gudkov et al., 1986) , or with a recombinant of td daPR-C containing ev sequences. The presence of ev sequences in the U5 region of PR2257/16 could be similarly explained. Although ev sequences were not found in a molecular clone of the td daPRC stock used to induce tumour PR2257, recombinations with RAV-0 sequences might have occurred in chicken during the long latency preceding the appearance of tumour 2257, and been transmitted during further passages in chicken and in quail. In agreement with this possibility, we were able to detect the presence of such a recombinant between td daPR-C and ev sequence by restriction enzyme analysis of C7 cell DNA (data not shown). The absence of ev sequences in the earliest passages of tumour 2257 which were investigated strongly suggests that these sequences were absent from the original src transducing virus. Therefore, these results do not support the hypothesis that ev sequences have played a role in the mechanism of transduction of this oncogene in PR2257.
